Patents by Inventor Taisuke Hoshi

Taisuke Hoshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230330081
    Abstract: Provided is a pharmaceutical composition for treating a tumor, comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxyl-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or its pharmaceutically acceptable salt, which is to be administered in combination with a PD-1 antagonist.
    Type: Application
    Filed: October 26, 2021
    Publication date: October 19, 2023
    Inventors: Taisuke HOSHI, Yu KATO, Yoichi OZAWA, Satoshi KAWANO, Kotaro KODAMA, Saori MIYANO
  • Publication number: 20210333281
    Abstract: Biomarkers are provided that predict whether a subject having a hepatocellular carcinoma is responsive to a therapy comprising soratenib or a pharmaceutically acceptable salt thereof. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for and treating a subject having, suspected of having, or at risk of developing a hepatocellular carcinoma.
    Type: Application
    Filed: October 2, 2019
    Publication date: October 28, 2021
    Inventors: Yasuhiro Funahashi, Yukinori Minoshima, Michio Kanekiyo, Saori Miyano, Taisuke Hoshi